Tysabri (tie-SAB-ree), the latest treatment for multiple sclerosis (MS)

There's a lot of excitement about Tysabri (tie-SAB-ree), the latest treatment for multiple sclerosis (MS).

Tysabri (natalizumab) is a monoclonal antibody. It blocks immune cells from entering the CNS and attacking nerves.

It can reduce relapse rates by more than 60%...in patients with the relapsing-remitting form of MS.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote